NexgenRx Inc. (NXG.V)
| Previous Close | 0.2400 |
| Open | 0.3000 |
| Bid | 0.2900 x 0 |
| Ask | 0.3000 x 0 |
| Day's Range | 0.2750 - 0.3000 |
| 52 Week Range | 0.1800 - 0.3200 |
| Volume | |
| Avg. Volume | 12,406 |
| Market Cap | 20.567M |
| Beta (5Y Monthly) | 0.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.01 (4.17%) |
| Ex-Dividend Date | Dec 28, 2023 |
| 1y Target Est | N/A |
- ACCESSWIRE
NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings
TORONTO, ON / ACCESSWIRE / May 17, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2024, with revenue of $4,292,731, Net Income of $460,949 and EBITDA of $770,837. ...
- ACCESSWIRE
NexgenRx Announces Annual Meeting Results
TORONTO, ON / ACCESSWIRE / May 16, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the results of its annual and special meeting (the "Meeting") of shareholders, which was held on Thursday, May 16, 2024. The Meeting was held, ...
- ACCESSWIRE
NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA
TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued revenue growth to $3,573,751 for the quarter ...
